Compare JPMorgan Ultra Short Income ETF (JPST) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Ultra Short Income ETF vs 10X Genomics Inc — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.46, while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| JPST | TXG | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $50.78 | $58.57 |
52-Week Low | $50.40 | $11.34 |
Market Cap | — | $7.61B |
Enterprise Value | — | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
